Bioceres Faces Summary Judgment Damages in Jasper Lake Ventures Lawsuit
BIOX is trading near its 52-week low of $0.301 (15% above the low) on elevated volume (2.9× avg).
Summary
Bioceres lost a summary judgment motion on damages in the Jasper Lake Ventures case, with the court awarding plaintiffs' requested amounts plus $1.4M in costs and fees. The company plans to appeal.
Key Events · Legal and Risk Events · BIOX
-
Summary Judgment Granted Against Bioceres
On September 18, 2026, the New York Supreme Court granted Plaintiffs' Motion for Summary Judgment on Damages in Jasper Lake Ventures One LLC, et al. v. Bioceres Crop Solutions Corp., et al., awarding damages in the amounts set forth in Plaintiffs' motion papers.
-
Damages Include Per Diem Interest
The award includes per diem interest from July 23, 2026 until judgment is entered, meaning the total liability continues to accrue daily.
-
$1.4M in Costs and Fees
The court also awarded $1.4 million in costs and attorneys' fees owed jointly and severally by all Defendants.
-
Company to Appeal
Bioceres and the Guarantor Defendants intend to appeal the Court's ruling, which could delay final resolution but does not eliminate the current judgment.
Analysis · BIOX · Industrial Applications And Services
A New York state court has granted summary judgment against Bioceres on damages in the Jasper Lake Ventures lawsuit, awarding the amounts sought by plaintiffs plus $1.4 million in costs and fees. The company intends to appeal, but the ruling creates a concrete, court-determined liability that could pressure an already-strained balance sheet — the company reported a $31.8M net loss in fiscal Q4 and is fighting to regain Nasdaq's $1.00 minimum bid price. The exact damages figure is not stated in the filing, but the award includes per diem interest accruing from July 23, 2026 until judgment is entered, meaning the total continues to grow.
How filings like this one have moved
In the 30 days to Sep 23, 2026, 35.1% of the 1081 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BIOX was trading at $0.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $22.8M. The 52-week trading range was $0.30 to $2.19. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.